Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Phenelzine | hsa00190 | Oxidative phosphorylation | 2.29E-02 | 2 | Q16718, O14521 | NDUFA5, SDHD | More | | Phenelzine | hsa00410 | beta-Alanine metabolism | 4.50E-02 | 1 | Q6ZQY3 | GADL1 | More | | Phenelzine | hsa00471 | D-Glutamine and D-glutamate metabolism | 2.28E-02 | 1 | Q7Z3D6 | C14orf159 | More | | Phenelzine | hsa00512 | Mucin type O-glycan biosynthesis | 3.78E-02 | 2 | O95395, Q8N4A0 | GCNT3, GALNT4 | More | | Phenelzine | hsa00520 | Amino sugar and nucleotide sugar metabolism | 2.24E-02 | 3 | Q16222, Q9Y223, P06865 | UAP1, GNE, HEXA | More | | Phenelzine | hsa00563 | Glycosylphosphatidylinositol (GPI)-anchor biosynthesis | 4.50E-02 | 1 | Q14442 | PIGH | More | | Phenelzine | hsa00565 | Ether lipid metabolism | 4.50E-02 | 1 | Q8N661 | TMEM86B | More | | Phenelzine | hsa00590 | Arachidonic acid metabolism | 2.95E-03 | 3 | P11712, P18054, P09960 | CYP2C9, ALOX12, LTA4H | More | | Phenelzine | hsa00591 | Linoleic acid metabolism | 1.58E-03 | 1 | P11712 | CYP2C9 | More | | Phenelzine | hsa00600 | Sphingolipid metabolism | 4.56E-02 | 3 | Q9BX95, Q06136, P06280 | SGPP1, FVT1, GLA | More | | Phenelzine | hsa00770 | Pantothenate and CoA biosynthesis | 2.28E-02 | 1 | Q6ZQY3 | GADL1 | More | | Phenelzine | hsa00970 | Aminoacyl-tRNA biosynthesis | 3.78E-02 | 2 | O95363, Q15046 | FARS2, KARS | More | | Phenelzine | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 1.45E-04 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | | Phenelzine | hsa00982 | Drug metabolism - cytochrome P450 | 1.45E-04 | 2 | P11712, P78417 | CYP2C9, GSTO1 | More | | Phenelzine | hsa02010 | ABC transporters | 2.29E-02 | 2 | P45844, P08183 | ABCG1, ABCB1 | More | | Phenelzine | hsa03013 | RNA transport | 1.91E-02 | 9 | P52298, O14893, P61326, Q7Z3B4, P35658, Q14152, O75822, P78345, Q9Y6A5 | NCBP2, GEMIN2, MAGOH, NUP54, NUP214, EIF3A, EIF3J, RPP38, TACC3 | More | | Phenelzine | hsa03022 | Basal transcription factors | 3.32E-02 | 2 | O00268, Q15544 | TAF4, TAF11 | More | | Phenelzine | hsa03040 | Spliceosome | 1.28E-05 | 13 | O43143, O60508, P08579, P26368, Q13595, Q07955, Q01130, P84103, Q13243, P11142, Q9Y2W2, O43447, O75643 | DHX15, CDC40, SNRPB2, U2AF2, TRA2A, SFRS1, SFRS2, SFRS3, SFRS5, HSPA8, WBP11, PPIH, ASCC3L1 | More | | Phenelzine | hsa04014 | Ras signaling pathway | 1.72E-03 | 11 | P42338, P20827, P49767, Q13009, P17252, Q7LDG7, Q14644, P0DP23, P63218, P50151, P19174 | PIK3CB, EFNA1, VEGFC, TIAM1, PRKCA, RASGRP2, RASA3, CALM1, GNG5, GNG10, PLCG1 | More | | Phenelzine | hsa04015 | Rap1 signaling pathway | 1.79E-02 | 8 | P20827, P49767, Q96FS4, P11215, Q13009, Q7LDG7, P42338, P19174 | EFNA1, VEGFC, SIPA1, ITGAM, TIAM1, RASGRP2, PIK3CB, PLCG1 | More | | Phenelzine | hsa04020 | Calcium signaling pathway | 8.12E-05 | 6 | P17252, Q93086, Q15746, P0DP23, P23634, P49767 | PRKCA, P2RX5, MYLK, CALM1, ATP2B4, VEGFC | More | | Phenelzine | hsa04022 | cGMP-PKG signaling pathway | 3.50E-02 | 3 | P23634, Q15746, P0DP23 | ATP2B4, MYLK, CALM1 | More | | Phenelzine | hsa04062 | Chemokine signaling pathway | 9.51E-04 | 11 | P10145, P09769, P07948, P42338, P19174, P63218, P50151, P43250, Q7LDG7, Q13009, Q8WYR1 | IL8, FGR, LYN, PIK3CB, PLCG1, GNG5, GNG10, GRK6, RASGRP2, TIAM1, PIK3R5 | More | | Phenelzine | hsa04064 | NF-kappa B signaling pathway | 2.83E-02 | 8 | P10415, Q13489, O00463, Q13546, Q9UDY8, Q13077, Q16548, P24522 | BCL2, BIRC3, TRAF5, RIPK1, MALT1, TRAF1, BCL2A1, GADD45A | More | | Phenelzine | hsa04071 | Sphingolipid signaling pathway | 1.03E-02 | 6 | P21453, Q9H228, Q16537, Q9BX95, Q16539, P10415 | S1PR1, EDG8, PPP2R5E, SGPP1, MAPK14, BCL2 | More | | Phenelzine | hsa04151 | PI3K-Akt signaling pathway | 3.70E-02 | 12 | P42338, P43657, P20827, P49767, P08238, Q8WYR1, P63218, P50151, O15335, Q13751, P14784, P30281 | PIK3CB, P2RY5, EFNA1, VEGFC, HSP90AB1, PIK3R5, GNG5, GNG10, CHAD, LAMB3, IL2RB, CCND3 | More | | Phenelzine | hsa04213 | Longevity regulating pathway - multiple species | 2.85E-02 | 2 | Q9Y4H2, Q13547 | IRS2, HDAC1 | More | | Phenelzine | hsa04261 | Adrenergic signaling in cardiomyocytes | 3.02E-02 | 3 | P0DP23, P17252, P23634 | CALM1, PRKCA, ATP2B4 | More | | Phenelzine | hsa04270 | Vascular smooth muscle contraction | 1.50E-02 | 3 | Q15746, P17252, P0DP23 | MYLK, PRKCA, CALM1 | More | | Phenelzine | hsa04360 | Axon guidance | 4.04E-02 | 6 | P16333, P20827, O95631, P42338, P07332, P19174 | NCK1, EFNA1, NTN1, PIK3CB, FES, PLCG1 | More | | Phenelzine | hsa04371 | Apelin signaling pathway | 1.00E-02 | 7 | P63218, P50151, Q8WYR1, Q14814, Q14344, Q13485, P84022 | GNG5, GNG10, PIK3R5, MEF2D, GNA13, SMAD4, SMAD3 | More | | Phenelzine | hsa04510 | Focal adhesion | 2.35E-02 | 4 | Q15746, P17252, Q13489, P49767 | MYLK, PRKCA, BIRC3, VEGFC | More | | Phenelzine | hsa04530 | Tight junction | 3.29E-02 | 3 | P16989, P56750, Q14247 | CSDA, CLDN17, CTTN | More | | Phenelzine | hsa04610 | Complement and coagulation cascades | 3.16E-03 | 2 | P00734, P0C0L4 | F2, C4A | More | | Phenelzine | hsa04613 | Neutrophil extracellular trap formation | 1.78E-06 | 21 | P11215, O60603, P05164, P08246, Q9UM07, Q13547, Q92769, P04908, Q6FI13, Q93077, P58876, P62807, Q16778, O60814, P68431, Q15080, O75015, P21730, P21462, O43315, Q16539 | ITGAM, TLR2, MPO, ELA2, PADI4, HDAC1, HDAC2, H2AC4; H2AC8, H2AC18; H2AC19, HIST1H2AC, H2BC5, HIST1H2BC, HIST2H2BE, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, NCF4, FCGR3B, C5AR1, FPR1, AQP9, MAPK14 | More | | Phenelzine | hsa04659 | Th17 cell differentiation | 1.70E-02 | 7 | P19174, P14784, P14778, P84022, Q13485, P08238, P07766 | PLCG1, IL2RB, IL1R1, SMAD3, SMAD4, HSP90AB1, CD3E | More | | Phenelzine | hsa04662 | B cell receptor signaling pathway | 1.74E-02 | 5 | P42338, P60033, P07948, P21854, Q8N149 | PIK3CB, CD81, LYN, CD72, LILRA2 | More | | Phenelzine | hsa04664 | Fc epsilon RI signaling pathway | 2.47E-02 | 4 | P42338, P07948, P19174, P09917 | PIK3CB, LYN, PLCG1, ALOX5 | More | | Phenelzine | hsa04668 | TNF signaling pathway | 4.96E-02 | 6 | O00463, Q13546, Q13489, Q16539, Q13077, P14780 | TRAF5, RIPK1, BIRC3, MAPK14, TRAF1, MMP9 | More | | Phenelzine | hsa04714 | Thermogenesis | 5.21E-03 | 4 | Q16539, P33121, Q16718, O14521 | MAPK14, ACSL1, NDUFA5, SDHD | More | | Phenelzine | hsa04720 | Long-term potentiation | 3.63E-02 | 2 | P17252, P0DP23 | PRKCA, CALM1 | More | | Phenelzine | hsa04726 | Serotonergic synapse | 1.50E-02 | 3 | P17252, P11712, P18054 | PRKCA, CYP2C9, ALOX12 | More | | Phenelzine | hsa04750 | Inflammatory mediator regulation of TRP channels | 9.58E-03 | 3 | P18054, P17252, P0DP23 | ALOX12, PRKCA, CALM1 | More | | Phenelzine | hsa04912 | GnRH signaling pathway | 3.63E-02 | 2 | P17252, P0DP23 | PRKCA, CALM1 | More | | Phenelzine | hsa04916 | Melanogenesis | 3.97E-03 | 3 | P0DP23, Q9UJU2, P17252 | CALM1, LEF1, PRKCA | More | | Phenelzine | hsa04921 | Oxytocin signaling pathway | 2.19E-02 | 3 | Q15746, P0DP23, P17252 | MYLK, CALM1, PRKCA | More | | Phenelzine | hsa04925 | Aldosterone synthesis and secretion | 5.51E-03 | 3 | P0DP23, P17252, P23634 | CALM1, PRKCA, ATP2B4 | More | | Phenelzine | hsa04932 | Non-alcoholic fatty liver disease | 3.62E-02 | 3 | P49841, Q16718, O14521 | GSK3B, NDUFA5, SDHD | More | | Phenelzine | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 3.21E-02 | 5 | P84022, Q13485, P42338, P49767, P19174 | SMAD3, SMAD4, PIK3CB, VEGFC, PLCG1 | More | | Phenelzine | hsa04961 | Endocrine and other factor-regulated calcium reabsorption | 1.40E-02 | 2 | P23634, P17252 | ATP2B4, PRKCA | More | | Phenelzine | hsa04970 | Salivary secretion | 3.97E-03 | 3 | P23634, P17252, P0DP23 | ATP2B4, PRKCA, CALM1 | More | | Phenelzine | hsa04971 | Gastric acid secretion | 5.51E-03 | 3 | P17252, P0DP23, Q15746 | PRKCA, CALM1, MYLK | More | | Phenelzine | hsa04972 | Pancreatic secretion | 1.40E-02 | 2 | P23634, P17252 | ATP2B4, PRKCA | More | | Phenelzine | hsa04976 | Bile secretion | 3.32E-02 | 2 | O43315, P08183 | AQP9, ABCB1 | More | | Phenelzine | hsa05020 | Prion disease | 3.80E-02 | 4 | Q16718, O14521, P49841, Q16539 | NDUFA5, SDHD, GSK3B, MAPK14 | More | | Phenelzine | hsa05022 | Pathways of neurodegeneration - multiple diseases | 1.24E-02 | 6 | P49841, Q16718, O14521, Q13561, Q16539, Q08752 | GSK3B, NDUFA5, SDHD, DCTN2, MAPK14, PPID | More | | Phenelzine | hsa05034 | Alcoholism | 2.05E-05 | 7 | Q13547, Q93077, P58876, P62807, Q16778, O60814, P68431 | HDAC1, HIST1H2AC, H2BC5, HIST1H2BC, HIST2H2BE, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Phenelzine | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 6.89E-03 | 2 | Q99437, P10145 | ATP6V0B, IL8 | More | | Phenelzine | hsa05133 | Pertussis | 1.73E-03 | 3 | P0DP23, P09871, P0C0L4 | CALM1, C1S, C4A | More | | Phenelzine | hsa05143 | African trypanosomiasis | 4.81E-02 | 2 | P69905, P68871 | HBA2, HBB | More | | Phenelzine | hsa05200 | Pathways in cancer | 9.46E-03 | 17 | Q13751, P42338, P08238, P19174, P43246, P84022, Q13485, Q13547, P30281, P49767, P43657, P63218, P50151, Q14344, Q7LDG7, O75293, P14784 | LAMB3, PIK3CB, HSP90AB1, PLCG1, MSH2, SMAD3, SMAD4, HDAC1, CCND3, VEGFC, P2RY5, GNG5, GNG10, GNA13, RASGRP2, GADD45B, IL2RB | More | | Phenelzine | hsa05202 | Transcriptional misregulation in cancer | 1.45E-04 | 16 | Q15532, P41732, P14780, P27930, Q16548, P11215, Q13489, Q13077, P35226, P05164, P08246, Q9C0K0, Q13547, Q92769, P12980, P24522 | SS18, TSPAN7, MMP9, IL1R2, BCL2A1, ITGAM, BIRC3, TRAF1, BMI1, MPO, ELA2, BCL11B, HDAC1, HDAC2, LYL1, GADD45A | More | | Phenelzine | hsa05203 | Viral carcinogenesis | 1.22E-03 | 6 | Q13547, Q15283, P58876, P62807, Q16778, O60814 | HDAC1, RASA2, H2BC5, HIST1H2BC, HIST2H2BE, H2BC12 | More | | Phenelzine | hsa05204 | Chemical carcinogenesis | 4.09E-04 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | | Phenelzine | hsa05212 | Pancreatic cancer | 3.94E-02 | 4 | P42338, P84022, Q13485, O75293 | PIK3CB, SMAD3, SMAD4, GADD45B | More | | Phenelzine | hsa05214 | Glioma | 4.55E-02 | 2 | P0DP23, P17252 | CALM1, PRKCA | More | | Phenelzine | hsa05217 | Basal cell carcinoma | 2.01E-02 | 4 | Q13635, P04628, Q9UJU2, P24522 | PTCH1, WNT1, LEF1, GADD45A | More | | Phenelzine | hsa05220 | Chronic myeloid leukemia | 2.16E-02 | 5 | Q13547, Q13485, P84022, P42338, O75293 | HDAC1, SMAD4, SMAD3, PIK3CB, GADD45B | More | | Phenelzine | hsa05322 | Systemic lupus erythematosus | 4.80E-06 | 7 | P09871, Q93077, P58876, P62807, Q16778, O60814, P68431 | C1S, HIST1H2AC, H2BC5, HIST1H2BC, HIST2H2BE, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Phenelzine | hsa05323 | Rheumatoid arthritis | 4.28E-02 | 2 | Q99437, P10145 | ATP6V0B, IL8 | More | | Phenelzine | hsa05415 | Diabetic cardiomyopathy | 1.28E-02 | 4 | Q16718, O14521, Q16539, P49841 | NDUFA5, SDHD, MAPK14, GSK3B | More | | |